Bruce A. Feinberg
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Economics and Econometrics top 5%
- Immunology
- Molecular Biology
- Co-authors
- Ajeet GajraJonathan KishChadi NabhanS. SaksMoshe TalpazJordan U. GuttermanRazelle KurzrockMarjorie E. Zettler
- Topics
- Economic and Financial Impacts of Cancer (34 papers)Health Systems, Economic Evaluations, Quality of Life (23 papers)CAR-T cell therapy research (20 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Bruce A. Feinberg
126 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 117
- Oncology 477
- Pulmonary and Respiratory Medicine 249
- Economics and Econometrics 229
- Immunology 206
- Molecular Biology 173
Countries citing papers authored by Bruce A. Feinberg
This map shows the geographic impact of Bruce A. Feinberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce A. Feinberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce A. Feinberg more than expected).
Fields of papers citing papers by Bruce A. Feinberg
This network shows the impact of papers produced by Bruce A. Feinberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce A. Feinberg. The network helps show where Bruce A. Feinberg may publish in the future.
Co-authorship network of co-authors of Bruce A. Feinberg
This figure shows the co-authorship network connecting the top 25 collaborators of Bruce A. Feinberg. A scholar is included among the top collaborators of Bruce A. Feinberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce A. Feinberg. Bruce A. Feinberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 31 | |
| 9 | 30 | |
| 10 | 1 | |
| 11 | 78 | |
| 12 | 10 | |
| 13 | 0 | |
| 14 | 1 | |
| 15 | CAR-T cells: the next era in immuno-oncology. | 2 |
| 16 | 1 | |
| 17 | 47 | |
| 18 | 1 | |
| 19 | 14 | |
| 20 | 21 |
About Bruce A. Feinberg
Bruce A. Feinberg is a scholar working on Oncology, Hematology and Economics and Econometrics, having authored 145 papers that have together received 1.2k indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (34 papers), Health Systems, Economic Evaluations, Quality of Life (23 papers) and CAR-T cell therapy research (20 papers). The work is most often cited by research in Oncology (477 citations), Immunology (206 citations) and Geriatrics and Gerontology (34 citations). Bruce A. Feinberg has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Ajeet Gajra, Jonathan Kish, Chadi Nabhan, S. Saks, Moshe Talpaz, Jordan U. Gutterman, Razelle Kurzrock, Marjorie E. Zettler, Mark Blick and Andrew J. Klink. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.